DeDora Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Buy
3,644
+244
+7% +$249K 0.95% 29
2026
Q1
$3.13M Sell
3,400
-10
-0.3% -$10.1K 0.77% 34
2025
Q4
$3.66M Buy
3,410
+301
+10% +$288K 0.87% 30
2025
Q3
$2.37M Buy
3,109
+118
+4% +$87.8K 0.57% 43
2025
Q2
$2.33M Buy
2,991
+233
+8% +$181K 0.61% 41
2025
Q1
$2.28M Buy
2,758
+257
+10% +$214K 0.66% 39
2024
Q4
$1.93M Sell
2,501
-6
-0.2% -$4.97K 0.53% 44
2024
Q3
$2.22M Buy
2,507
+267
+12% +$240K 0.62% 38
2024
Q2
$2.03M Buy
2,240
+88
+4% +$70.4K 0.62% 38
2024
Q1
$1.67M Buy
2,152
+375
+21% +$267K 0.53% 46
2023
Q4
$1.04M Buy
1,777
+45
+3% +$26.3K 0.36% 55
2023
Q3
$930K Buy
1,732
+330
+24% +$170K 0.37% 54
2023
Q2
$657K Buy
1,402
+685
+96% +$287K 0.25% 73
2023
Q1
$246K Sell
717
-184
-20% -$62.1K 0.11% 95
2022
Q4
$330K Sell
901
-180
-17% -$63.8K 0.16% 89
2022
Q3
$349K Buy
1,081
+1
+0.1% +$317 0.18% 79
2022
Q2
$350K Buy
1,080
+16
+2% +$4.8K 0.18% 76
2022
Q1
$305K Buy
+1,064
New +$274K 0.12% 82
2021
Q4
Sell
-1,138
Closed -$263K 83
2021
Q3
$263K Sell
1,138
-79
-6% -$19.5K 0.11% 86
2021
Q2
$279K Sell
1,217
-37
-3% -$7.43K 0.12% 86
2021
Q1
$234K Buy
1,254
+3
+0.2% +$587 0.11% 88
2020
Q4
$211K Buy
+1,251
New +$187K 0.1% 84

Other funds holding LLY

DeDora Capital's LLY Position: Q2 2026 in Review

DeDora Capital increased its Eli Lilly (LLY) stake by 7.2% in Q2 2026, buying an estimated $249K and bringing the position to 3,644 shares worth $4.37M. The position accounts for 0.95% of the portfolio, ranked #29.

DeDora Capital first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. 1,799 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • DeDora Capital held 3,644 shares of Eli Lilly worth $4.37M as of Q2 2026.
  • DeDora Capital bought 244 Eli Lilly shares in Q2 2026, an estimated $249K.
  • Eli Lilly made up 0.95% of DeDora Capital's portfolio in Q2 2026, its #29 holding.
  • DeDora Capital first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • 1,799 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DeDora Capital's 13F filing for Q2 2026, filed 13 Jul 2026.